URGENT ALERT! People with Anapen adrenaline injector advised to see their GP after recall of the device
The Medicines and Healthcare products Regulatory Agency (MHRA) today (23.05.2012) issued an alert to healthcare professionals and is advising people who suffer from severe allergic reactions to see their GP or allergy clinic as soon as possible to discuss alternative products after Anapen was precautionarily recalled by the licence holder Lincoln Medical Limited.
A potential problem with the speed and delivery of adrenaline by the Anapen injectors was found during development work by the manufacturer Owen Mumford Ltd. No problems with these injectors have been reported by people or healthcare professionals but in the worst case scenario, the injector could fail to deliver adrenaline in an emergency situation when a person has a severe allergic reaction caused by peanuts or other foods, insect bites or stings.
People with the injectors below are advised to continue using their Anapen injectors until they can discuss using alternative products with their GP or clinic.
- Anapen 500 micrograms in 0.3ml solution for injection in a pre-filled syringe PL 18813/0003
- Anapen 300 micrograms in 0.3ml solution for injection in a pre-filled syringe PL 18813/0001
- Anapen Junior 150 micrograms in 0.3ml solution for injection in a pre-filled syringe PL 18813/0002
Gerald Heddell, the MHRA’s Director of Inspection, Enforcement and Standards, said:
“This is a precautionary recall and no problems with Anapen adrenaline injectors have been reported by people or healthcare professionals. People should continue to use their existing Anapen injectors until they can obtain an alternative product and they should make an appointment with their GP or clinic as soon as possible to discuss this.”
IMPORTANT! This alert only applies to the Anapen adrenaline injector. No other adrenaline injectors are affected.
Call the Anaphylaxis Campaign's helpline on 01252 542029 if you are worried or have urgent questions.
